Top Consumer Driven Health Care Stories
Class-action suit over insulin prices gets green light
By Jef Feeley and Robert LangrethPlaintiffs contend companies are illegally raising insulin prices to provide rebates for pharmacy-benefit managers who decide which drugs get on preferred insurance lists.










